Tiltan Pharma Raises $1.5 MillionThe capital is intended for the completion of the ongoing Phase 2 clinical trial of TL-118, for the treatment of metastatic pancreatic cancer Tiltan Pharma Raises $1.5 MillionMoni Horovitz2022-09-06T11:26:32+00:00
